Enclomiphene raises testosterone through the body's own HPT axis while preserving sperm — unlike TRT which suppresses both. This 2026 guide covers the Phase III trial evidence (+274 ng/dL in 10-RCT meta-analysis), the HPT axis mechanism, full enclomiphene vs TRT vs clomiphene comparison table, FDA regulatory status (not approved — May 2026), side effects, and who it is and is not appropriate for.

Up to 6 million American men have low testosterone — but most are undiagnosed because symptoms like fatigue, low mood, and reduced libido are easily attributed to stress or ageing. This complete guide covers all Low T symptoms across sexual, physical, psychological, and metabolic domains, the primary and secondary causes including obesity and opioid use, how diagnosis requires two morning blood tests with symptoms, and the full treatment options table covering gels, patches,